These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 29932250)
1. Effects of panax notoginseng saponin on the pathological ultrastructure and serum IL-6 and IL-8 in pulmonary fibrosis in rabbits. Zhang J; Li Q; Shao Q; Song J; Zhou B; Shu P J Cell Biochem; 2018 Nov; 119(10):8410-8418. PubMed ID: 29932250 [TBL] [Abstract][Full Text] [Related]
2. Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: Association with the NF-κB signaling pathway. Wang Y; Sun X; Xie Y; Du A; Chen M; Lai S; Wei X; Ji L; Wang C J Ethnopharmacol; 2024 Jan; 319(Pt 1):117135. PubMed ID: 37689326 [TBL] [Abstract][Full Text] [Related]
3. Panax notoginseng saponin R1 modulates TNF-α/NF-κB signaling and attenuates allergic airway inflammation in asthma. Xue K; Ruan L; Hu J; Fu Z; Tian D; Zou W Int Immunopharmacol; 2020 Nov; 88():106860. PubMed ID: 32771949 [TBL] [Abstract][Full Text] [Related]
4. Protective Effect of Panax Notoginseng Saponins on Apolipoprotein-E-deficient Atherosclerosis-prone Mice. Yang H; Liu Z; Hu X; Liu X; Gui L; Cai Z; Dai C Curr Pharm Des; 2022; 28(8):671-677. PubMed ID: 35088656 [TBL] [Abstract][Full Text] [Related]
5. Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression. Fan JS; Liu DN; Huang G; Xu ZZ; Jia Y; Zhang HG; Li XH; He FT J Ethnopharmacol; 2012 Aug; 142(3):732-8. PubMed ID: 22683903 [TBL] [Abstract][Full Text] [Related]
6. Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo. Shi X; Yu W; Yang T; Liu W; Zhao Y; Sun Y; Chai L; Gao Y; Dong B; Zhu L J Ethnopharmacol; 2016 Aug; 190():301-12. PubMed ID: 27288754 [TBL] [Abstract][Full Text] [Related]
7. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway. Fan J; Liu D; He C; Li X; He F J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662 [TBL] [Abstract][Full Text] [Related]
8. Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation. Yuan Z; Liao Y; Tian G; Li H; Jia Y; Zhang H; Tan Z; Li X; Deng W; Liu K; Zhang Y J Ethnopharmacol; 2011 Oct; 138(1):150-5. PubMed ID: 21924337 [TBL] [Abstract][Full Text] [Related]
9. Total Saponins of Panax Notoginseng Modulate the Astrocyte Inflammatory Signaling Pathway and Attenuate Inflammatory Injury Induced by Oxygen- Glucose Deprivation/Reperfusion Injury in Rat Brain Microvascular Endothelial Cells. Wei X; Wen Y; Hu Y; Guo X Curr Stem Cell Res Ther; 2024; 19(2):267-276. PubMed ID: 37218204 [TBL] [Abstract][Full Text] [Related]
10. Panax notoginseng saponin alleviates pulmonary fibrosis in rats by modulating the renin-angiotensin system. Li H; Wang YG; Chen TF; Gao YH; Song L; Yang YF; Gao Y; Huo W; Zhang GP J Ethnopharmacol; 2024 Jan; 318(Pt B):116979. PubMed ID: 37532070 [TBL] [Abstract][Full Text] [Related]
11. Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits. Liu Y; Zhang HG; Jia Y; Li XH Biol Pharm Bull; 2010; 33(8):1324-30. PubMed ID: 20686226 [TBL] [Abstract][Full Text] [Related]
12. Zhao Y; Zheng J; Yu Y; Wang L Biomed Res Int; 2018; 2018():9239354. PubMed ID: 30151392 [No Abstract] [Full Text] [Related]
13. Clinical Observation of Salvianolic Acid Combined with Panax Notoginseng Saponins Combined with Basic Nursing Intervention on Cerebral Ischemia-Reperfusion Injury in Rats. Zheng Z; Liang S; Sun S; Liu P; Yu L J Healthc Eng; 2022; 2022():8706730. PubMed ID: 35136538 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice. Liu L; Shi R; Shi Q; Cheng Y; Huo Y Planta Med; 2008 Feb; 74(3):203-9. PubMed ID: 18260050 [TBL] [Abstract][Full Text] [Related]
15. [Effect of Panax notoginseng saponins on cytokines in liver fibrosis rats]. Jiang H; Wang YZ; Liu XC; Xue X Zhong Yao Cai; 2013 Jul; 36(7):1123-7. PubMed ID: 24417151 [TBL] [Abstract][Full Text] [Related]
16. Protective effects of panax notoginseng saponin on dextran sulfate sodium-induced colitis in rats through phosphoinositide-3-kinase protein kinase B signaling pathway inhibition. Lu QG; Zeng L; Li XH; Liu Y; Du XF; Bai GM; Yan X World J Gastroenterol; 2020 Mar; 26(11):1156-1171. PubMed ID: 32231420 [TBL] [Abstract][Full Text] [Related]
17. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action. Zhang YG; Zhang HG; Zhang GY; Fan JS; Li XH; Liu YH; Li SH; Lian XM; Tang Z Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1238-44. PubMed ID: 18637019 [TBL] [Abstract][Full Text] [Related]
18. [Effect of Panax notoginseng saponins on expressions of MMP-13 and TIMP-1 in rats with hepatic fibrosis]. Jiang H; Xia LZ; Li Y; Li X; Wu J Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(8):1206-10. PubMed ID: 23944037 [TBL] [Abstract][Full Text] [Related]
19. Panax notoginseng saponins inhibit areca nut extract-induced oral submucous fibrosis in vitro. Dai JP; Chen XX; Zhu DX; Wan QY; Chen C; Wang GF; Li WZ; Li KS J Oral Pathol Med; 2014 Jul; 43(6):464-70. PubMed ID: 24484214 [TBL] [Abstract][Full Text] [Related]
20. [Effects of Panax notoginseng saponins on pneumocyte apoptosis and c-Jun N-terminal kinase in lung ischemia/reperfusion injury]. Qiu XX; Song ZJ; Dai YY; Fang ZX; Wang WT Sheng Li Xue Bao; 2012 Apr; 64(2):135-41. PubMed ID: 22513462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]